Eldred L - Search Results

1

Comparative immunogenicity of plasma and recombinant hepatitis B virus vaccines in homosexual men.

Odaka N, Eldred L, Cohn S, Muñoz A, Fields HA, Fox R, Solomon R, Kaslow R, Polk BF. Odaka N, et al. Among authors: eldred l. JAMA. 1988 Dec 23-30;260(24):3635-7. JAMA. 1988. PMID: 2973531 Clinical Trial.

2

Dermatologic findings associated with human immunodeficiency virus infection.

Matis WL, Triana A, Shapiro R, Eldred L, Polk BF, Hood AF. Matis WL, et al. Among authors: eldred l. J Am Acad Dermatol. 1987 Nov;17(5 Pt 1):746-51. doi: 10.1016/s0190-9622(87)70257-6. J Am Acad Dermatol. 1987. PMID: 3680653

3

Clinical manifestations of acute infection with human immunodeficiency virus in a cohort of gay men.

Fox R, Eldred LJ, Fuchs EJ, Kaslow RA, Visscher BR, Ho M, Phair JP, Polk BF. Fox R, et al. Among authors: eldred lj. AIDS. 1987 May;1(1):35-8. AIDS. 1987. PMID: 3122787

4

Antiretroviral therapy, interferon sensitivity, and virologic setpoint in human immunodeficiency virus/hepatitis C virus coinfected patients.

Balagopal A, Kandathil AJ, Higgins YH, Wood J, Richer J, Quinn J, Eldred L, Li Z, Ray SC, Sulkowski MS, Thomas DL. Balagopal A, et al. Among authors: eldred l. Hepatology. 2014 Aug;60(2):477-86. doi: 10.1002/hep.27158. Epub 2014 May 14. Hepatology. 2014. PMID: 24706559 Free PMC article. Clinical Trial.

5

Duration of human immunodeficiency virus infection and likelihood of giving birth in a Medicaid population in Maryland.

Lee LM, Wortley PM, Fleming PL, Eldred LJ, Gray RH. Lee LM, et al. Among authors: eldred lj. Am J Epidemiol. 2000 May 15;151(10):1020-8. doi: 10.1093/oxfordjournals.aje.a010130. Am J Epidemiol. 2000. PMID: 10853641

6

Adherence to antiretroviral and pneumocystis prophylaxis in HIV disease.

Eldred LJ, Wu AW, Chaisson RE, Moore RD. Eldred LJ, et al. J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Jun 1;18(2):117-25. doi: 10.1097/00042560-199806010-00003. J Acquir Immune Defic Syndr Hum Retrovirol. 1998. PMID: 9637576

7

Predictors of sharing injection equipment by HIV-seropositive injection drug users.

Latkin CA, Buchanan AS, Metsch LR, Knight K, Latka MH, Mizuno Y, Knowlton AR; Intervention for Seropositive Injectors--Research Evaluation Team. Latkin CA, et al. J Acquir Immune Defic Syndr. 2008 Dec 1;49(4):447-50. doi: 10.1097/qai.0b013e31818a6546. J Acquir Immune Defic Syndr. 2008. PMID: 19186356 Free PMC article.

8

Clinical manifestations and risk factors of Pseudomonas aeruginosa infection in patients with AIDS.

Dropulic LK, Leslie JM, Eldred LJ, Zenilman J, Sears CL. Dropulic LK, et al. Among authors: eldred lj. J Infect Dis. 1995 Apr;171(4):930-7. doi: 10.1093/infdis/171.4.930. J Infect Dis. 1995. PMID: 7706821

9

Update on adherence to HIV therapy.

Eldred L, Cheever L. Eldred L, et al. Hopkins HIV Rep. 1998 Jan;10(1):10-1. Hopkins HIV Rep. 1998. PMID: 11365131

10

Seroconversion, sexual activity, and condom use among 2915 HIV seronegative men followed for up to 2 years.

Detels R, English P, Visscher BR, Jacobson L, Kingsley LA, Chmiel JS, Dudley JP, Eldred LJ, Ginzburg HM. Detels R, et al. Among authors: eldred lj. J Acquir Immune Defic Syndr (1988). 1989;2(1):77-83. J Acquir Immune Defic Syndr (1988). 1989. PMID: 2918462

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

57 results

Search Page

Filters